Damage-associated molecular patterns and immunogenic cancer cell death in cancer immunotherapy KU Leuven
My research is focused on cancer immunology and immunotherapy (e.g. anticancer vaccines, immunogenic cell death, immune effector responses), photodynamic therapy, combinatorial therapies involving chemo-(radio-)therapy and novel immunostimulatory factors (e.g. damage-associated molecular patterns/DAMPs, chemokines and cytokines). I have (and continue to) delineated novel cancer signalling (e.g. danger signalling, immunogenic signalling, ...